Kalaris Therapeutics Inc.
Strengths right arrow 13 S
Weakness right arrow 6 W
Opportunity right arrow 1 O
Threats right arrow 2 T
What is SWOT Analysis ?
Strengths, Weaknesses, Opportunities and Threats Analysis is a real time check on stock health throughout the day. SWOT looks at financials, management quality, technical parameters and valuations to identify positives and negatives for every stock.
These are then classified as strengths, weaknesses, opportunities that investors can leverage, and threats that might impact company health.
  • Strengths
  • Weakness
  • Opportunity
  • Threats
  • Significant (over 30%) distance from 52 week high
  • Rising Net Cash Flow and Cash from Operating activity
  • Relative Outperformance versus Industry over Half Year (6 Months)
  • Relative Outperformance versus Industry over the Quarter (3 Months)
  • Relative Outperformance versus Industry over 1 Year
  • Annual Profit Growth higher than Sector Profit Growth
  • PEG lower than Industry PEG
  • High Momentum Scores (Technical Scores greater than 50)
  • Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  • Stock with Low PE (PE < = 10)
  • Highest Recovery from 52 Week Low
  • Stocks Outperforming their Industry Price Change in the Quarter
  • Stocks with Expensive Valuations according to the Trendlyne Valuation Score
  • Top Losers
  • Low Piotroski Score : Companies with weak financials
  • Book Value Per Share deteriorating for last 2 years
  • RSI indicating price weakness
  • Top Losers
  • Mutual Funds Increased Shareholding in Past Month
  • MFs decreased their shareholding last quarter
  • Institutions decreased their shareholding last quarter
Trendlyne